Per MD - Strongbridge Biopharma Insider

SBBP -- USA Stock  

USD 6.75  0.55  8.87%

Founder and Sr. Clinical Advisor

We currently do not have informatin regarding Per MD. This executive tanure with Strongbridge Biopharma plc is not currenlty determined.

Management Efficiency

The company has return on total asset (ROA) of (25.16) % which means that it has lost $25.16 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (556.52) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 76.14 M in liabilities. Strongbridge Biopharma plc has Current Ratio of 8.71 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Entity Summary

Strongbridge Biopharma plc, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs. Strongbridge Biopharma plc was founded in 1996 and is headquartered in Trevose, Pennsylvania. Strongbridge Biopharma operates under Biotechnology classification in USA and traded on NASDAQ. It employs 66 people.Strongbridge Biopharma plc (SBBP) is traded on NASDAQ in USA. It is located in PENNSYLVANIA, U.S.A and employs 66 people. Strongbridge Biopharma is listed under Pharmaceutical Products category by Fama And French industry classification.

Strongbridge Biopharma Leadership Team

Matthew Pauls, CEO, MBA
Brian Davis, CFO, MBA
Richard Kollender, Director
Davis, CFO, MBA
Robert Lutz, Executive, MBA
Garheng Kong, Director, MBA
John Johnson, Chairman
Marten Steen, Director, Ph.D
Stephen Long, Executive
Ruth MD, Executive
Ruth ThieroffEkerdt, Executive, Ph.D
Hilde Steineger, Director, Ph.D
Per MD, Founder

Stock Performance Indicators

Did you try this?

Run Piotroski F Score Now

Piotroski F Score

Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
All  Next Launch Piotroski F Score

Trending Equities

Currently Active Assets on Macroaxis
Purchased over 100 shares of
over a week ago
Traded for 10.44
Purchased over 300 shares of
over a week ago
Traded for 6.24
Purchased over 70 shares of
over a week ago
Traded for 23.42
Purchased over 200 shares of
over a week ago
Traded for 8.1
Purchased over 400 shares of
over a week ago
Traded for 4.74
Also please take a look at World Market Map. Please also try Piotroski F Score module to get piotroski f score based on binary analysis strategy of nine different fundamentals.